Ivex Pharmaceuticals

Ivex Pharmaceuticals was a prominent American generic pharmaceutical company headquartered in Northbrook, Illinois. The company specialized in the development, manufacture, and marketing of generic prescription drugs, with a particular focus on complex dosage forms including injectables and respiratory products. Ivex established a significant market presence by targeting niche generic opportunities and maintaining a diverse portfolio of Abbreviated New Drug Applications (ANDAs). In December 2005, the company was acquired by Teva Pharmaceutical Industries for approximately $3.4 billion in a strategic move to bolster Teva's position in the U.S. generics market. Following the acquisition, Ivex's operations were integrated into Teva's global manufacturing and distribution network.